'Like the Titanic': Survey shows precarious state of U.S. science

A STAT survey of NIH-funded researchers reveals that, a year after Trump's return to the White House, many academic scientists are reeling. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

March 19, 2026 Check out STAT+

Sponsored By

Daniel Berman for STAT National survey of NIH-funded researchers shows precarious state of U.S. science — 'This is like the Titanic' A national STAT survey shows NIH funding disruptions are forcing layoffs, lab closures, and driving early-career scientists away from research careers. By Jonathan Wosen Researchers surveyed by STAT detail the toll of grant cuts: labs shutting down, data unanalyzed Interviews reveal stalled experiments and uncertain futures as NIH-funded researchers navigate disruptions highlighted in a STAT survey. By Jonathan Wosen and Anil Oza STAT+ | Senate Democrats lay out plans to overhaul health insurance after setbacks under Trump Democrats sharpen health care messaging as midterms loom, offering voters an outline of what they support, not just the Trump cuts they oppose. By John Wilkerson Mike Reddy for STAT The indirect — and sometimes surprising — benefits of vaccines There are major public health gains we take for granted, and potentially stand to lose, if vaccination rates fall amid backlash. By Helen Branswell STAT+ | HHS watchdog slams nursing homes' antipsychotic drug use and schizophrenia diagnoses  Federal watchdog says nursing homes use antipsychotic drugs as 'chemical restraints' on dementia patients, disguise practice as schizophrenia treatment. By Tara Bannow STAT+ | Novo Nordisk's high-dose Wegovy approved in the U.S. The FDA's decision gives the Danish drugmaker a new catalyst in the obesity drug race involving Eli Lilly and other companies. By Elaine Chen Molly Ferguson/STAT STAT+ | Six drugmakers, six months: Charting the FDA's course in the post-Prasad era In this week's "Adam's Biotech Scorecard," Adam points out what to look for to get a better sense of the FDA's positions of regulatory flexibility. By Adam Feuerstein STAT+ | Eli Lilly's 'triple-G' drug leads to significant blood sugar, weight reductions in diabetes trial Late-stage study of the drug, an injectable called retatrutide, could raise questions about too much weight loss in some patients. By Elaine Chen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser